Cambridge, United States
Data4Cure, Inc., founded in 2013 in the United States, is at the forefront of applying AI to biomedical challenges under the slogan, “Biomedical Intelligence. Turning data into cures.” Primarily operating within the AI, Analytics, Biotechnology, Education, Health Care, and Life Sciences domains, the company has carved out a niche in creating biology-informed AI tools that drive drug discovery and development efforts.
Their flagship product, the Biomedical Intelligence® Cloud, empowers pharmaceutical and biotech companies by transforming multimodal data into actionable knowledge. With an extensive knowledge graph that integrates over 3 billion chemical, biological, and clinical relations, this platform facilitates unprecedented insights into complex biological mechanisms.
The company's latest AI advancements include automated data curation and Knowledge Graph AI-based target intelligence. Data4Cure received its most recent investment of $800.00K in a Series A round from QB3 on April 1, 2014. Given their innovation and strategic market position, Data4Cure represents a strong opportunity for investors interested in the intersection of AI and life sciences.
